These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Immune response to sulfamethoxazole in patients with AIDS. Daftarian MP; Filion LG; Cameron W; Conway B; Roy R; Tropper F; Diaz-Mitoma F Clin Diagn Lab Immunol; 1995 Mar; 2(2):199-204. PubMed ID: 7697529 [TBL] [Abstract][Full Text] [Related]
48. Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection. Wong YY; Rakasz EG; Gasper DJ; Friedrich TC; Trepanier LA Toxicology; 2016 Aug; 368-369():10-18. PubMed ID: 27565715 [TBL] [Abstract][Full Text] [Related]
49. Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem? Alappan R; Buller GK; Perazella MA Am J Nephrol; 1999; 19(3):389-94. PubMed ID: 10393376 [TBL] [Abstract][Full Text] [Related]
50. [Side effects of trimethoprim-sulfamethoxazole in patients with AIDS]. Weinke T; Sixt C; de Matos-Marques B; Ruf B; Pohle HD Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1129-33. PubMed ID: 3260553 [TBL] [Abstract][Full Text] [Related]
51. [Drug hypersensitivity in AIDS patients: report of a case]. Ribeiro LM; Pastorino AC; Grumach AS; Jacob CM Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(1):23-7. PubMed ID: 9334468 [TBL] [Abstract][Full Text] [Related]
52. Successful treatment of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in hypersensitive AIDS patients. Gibbons RB; Lindauer JA JAMA; 1985 Mar; 253(9):1259-60. PubMed ID: 3871490 [No Abstract] [Full Text] [Related]
54. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children. Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071 [TBL] [Abstract][Full Text] [Related]
55. The acquired immunodeficiency syndrome and a trimethoprim-sulfamethoxazole adverse reaction. Cohn DL; Penley KA; Judson FN; Kirkpatrick CH; Horsburgh CR; Davis KC Ann Intern Med; 1984 Feb; 100(2):311. PubMed ID: 6607009 [No Abstract] [Full Text] [Related]
56. Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity. O'Neil WM; MacArthur RD; Farrough MJ; Doll MA; Fretland AJ; Hein DW; Crane LR; Svensson CK J Clin Pharmacol; 2002 Jun; 42(6):613-9. PubMed ID: 12043950 [TBL] [Abstract][Full Text] [Related]
57. Trimethoprim/sulfamethoxazole induced multiorgan dysfunction. Lee JS; Owshalimpur D; Schofield C BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23257644 [TBL] [Abstract][Full Text] [Related]
58. Trimethoprim is a potassium-sparing diuretic like amiloride and causes hyperkalemia in high-risk patients. Perazella MA Am J Ther; 1997; 4(9-10):343-8. PubMed ID: 10423629 [TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Piketty C; Gilquin J; Kazatchkine MD J Infect Dis; 1995 Aug; 172(2):611. PubMed ID: 7622921 [No Abstract] [Full Text] [Related]
60. Successful desensitization in a child with delayed cotrimoxazole hypersensitivity: A case report. D'Amelio CM; Del Pozo JL; Vega O; Madamba R; Gastaminza G Pediatr Allergy Immunol; 2016 May; 27(3):320-1. PubMed ID: 26660294 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]